1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Prostate Cancer Research Program (PCRP) Clinical Consortium Award is sponsored by Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP). The FY25 PCRP Clinical Consortium Award provides support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute phase 2 or phase 2-linked phase 1 (phase 1/2) prostate cancer clinical trials.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Prostate Cancer Research Program, Award Applications Recommended for Funding, Congressionally Directed Medical Research Programs You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research Award Applications Recommended for Funding FY25 Award Applications Recommended for Funding FY25 Clinical Consortium Award - Clinical Research Site Published: April 14, 2026 FY25 Clinical Consortium Award - Coordinating Center Published: April 14, 2026 FY25 Idea Development Award - Established Investigator Published: April 14, 2026 FY25 Idea Development Award - New Investigator Published: April 14, 2026 FY25 PCRP Information Paper Published: April 14, 2026 Sunday, December 31, 1600
According to the current listing, eligibility includes: Organizations capable of forming a clinical consortium for prostate cancer clinical trials. Confirm the full requirements in the official notice before applying.
Prostate Cancer Research Program (PCRP) Clinical Consortium Award is funded by Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Lupus Research Program Idea Award (FY26) is sponsored by Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP). Supports high-impact lupus research to advance understanding, diagnosis, treatment, and quality of life for people affected by lupus. This is one of several award mechanisms under the FY26 Lupus Research Program.
Traumatic Brain Injury New Investigator Award is sponsored by Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP). This award supports independent established scientists or clinicians with limited or no prior TBI research experience, and junior faculty within 5 years of their last fellowship/postdoctoral position, to become established TBI researchers.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article